Clinical Trials Logo

Clinical Trial Summary

Mobile medical devices for self-patient-use, are a rapidly evolving component of telehealth. Study examines the feasibility of using the INSTINCT® device, a portable self-use ultrasound system attached to a commercial smartphone in remote pregnancy assessment. Study aims to evaluate its safety, efficacy and usability.


Clinical Trial Description

Study includes women carrying a singleton fetus at 14 to 40 gestational weeks. Women with multiple gestations, non-viable fetus at recruitment and those with a major fetal anatomical malformation or genetic syndrome are excluded. Each participant receives the device for a self-use period of 7-14 days, instructed to preform 1-3 scans a day. Each participant completes a self-assessment questionnaire which aims to evaluate satisfactory and usability (user experience and satisfaction). Each scan will be evaluated for the possibility to properly view fetal heart activity, amniotic fluid volume, fetal tone, fetal body and breathing movements. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04399408
Study type Interventional
Source PulseNmore
Contact
Status Completed
Phase N/A
Start date May 6, 2019
Completion date July 25, 2020

See also
  Status Clinical Trial Phase
Completed NCT02456753 - Assesment by Ultrasonography of the Perineal-cephalic Distance N/A
Enrolling by invitation NCT04866537 - Evaluation of the Diagnostic Performance of Specialized Fetal Cardiac Ultrasound in the CPDPN - Arc Alpin Network
Completed NCT04441866 - Automated Analysis Algorithms in Second Trimester Obstetric Ultrasound N/A
Not yet recruiting NCT03206281 - Tall Stature Women Fetal Weight Estimation N/A